Both C-Heat (SME-1) and C-HEAT (SME-2) center on optimizing and scaling up a biomass condensation technology for energy-efficient, long-duration heat delivery.
BIOCURVE
Spanish SME developing biomass condensation heating technology for efficient, long-duration renewable heat generation.
Their core work
BIOCURVE is a Spanish SME based in Zaragoza that develops biomass-based condensation heat technology — specifically, energy-efficient heating systems that extract additional thermal energy through condensation processes using biomass as fuel. Their flagship technology, Condensed Heat (C-HEAT), focuses on optimizing and scaling up this approach to deliver longer-duration, higher-efficiency heat output compared to conventional biomass boilers. They successfully progressed through both phases of the EU SME Instrument, moving from concept validation to full-scale development and commercialization — a path only a small fraction of applicants complete. Their work sits at the intersection of renewable energy and industrial heat supply.
What they specialise in
All H2020 activity falls under the Energy pillar (P3-ENERGY), indicating sustained focus on low-carbon heat production from biomass feedstocks.
BIOCURVE used the SME Instrument two-phase pathway — Phase 1 feasibility (€50,000) followed by Phase 2 scale-up (€672,858) — demonstrating capability to advance a technology from concept to market.
How they've shifted over time
BIOCURVE's entire H2020 record spans 2015–2018 and is built around a single technology: biomass condensation heat. In the early phase (SME-1, 2015–2016) they were validating feasibility; by the later phase (SME-2, 2016–2018) they had moved into optimization and scale-up, suggesting meaningful technical progress within that window. There is no data indicating activity after 2018, so it is impossible to assess whether their focus has shifted or whether they have pursued other funding channels since.
Based on available data, BIOCURVE was on a clear commercialization trajectory with their C-HEAT technology through 2018, but there is no evidence of subsequent EU-funded activity, making their current direction uncertain.
How they like to work
BIOCURVE operates exclusively as a project coordinator, having led both of their H2020 projects independently — a pattern typical of SME Instrument grants, which are designed for single-company innovation rather than multi-partner consortia. With only one unique consortium partner across both projects, they work in very small or solo configurations rather than broad networks. This suggests they are a self-reliant technology developer that carries their own IP and prefers to control project direction rather than join as a supporting partner.
BIOCURVE has worked with just one consortium partner in one country across all their H2020 activity, reflecting the solo-innovator structure of the SME Instrument. Their collaborative footprint is minimal and entirely Spain-based.
What sets them apart
BIOCURVE is one of the few Spanish SMEs to complete the full SME Instrument two-phase journey in the energy sector, which signals a technology that passed independent EU expert review twice — once for viability and once for scale-up potential. Their differentiation lies in proprietary condensation technology applied to biomass heating, a niche that sits between the mature biomass boiler market and the emerging thermal energy storage space. For a consortium seeking a specialized, IP-owning SME in renewable heat, they represent a focused technology asset rather than a broad service provider.
Highlights from their portfolio
- C-HEATThe Phase 2 SME Instrument grant of €672,858 represents a significant commercialization investment in biomass condensation technology and confirms the concept survived rigorous EU feasibility review in Phase 1.
- C-HeatThe Phase 1 grant (€50,000) marks the starting point of BIOCURVE's technology validation journey and is notable as evidence that their core concept was independently assessed as viable.